Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 25, 2019 1:43pm
96 Views
Post# 29670441

RE:CcAbbott88

RE:CcAbbott88
Kishmere wrote:
please explain if salp changes their current mind 2)salp current ? ... You dont think Consonance will take part in rights! What if they do take part in rights?...... Also you think 6.7 to 20 shares per right. Yikes! Alot of if ands or buts in your qualified statements! "1. the rights offer will commencein May. 2. It'snotSALP's current intention to take part in the rights offer. I don't think that Consonance will take part either. Therefore the original estimate of between6.7 to 20is probably correct, depending on how fully the eligible 736 M shares "


I think that they have already set up the $75M cap on the rights offer and therefore do not need to put in more money than what they already put in.

They already has the control of the company and reset the balance sheet.  Regardless the final amount raised in the rights offer (up to $75M), they will maintain their position as the majority share holder.

However, I think that I understand your grievances and mistrust of the company and SALP and Consonance at this point.

Nevertheless, to take part in the rights offer is still the best way, imo, to lower your cost average, whatever you do decide to do with your investment in the future.

Or you can close your position now, and take the loss.  GL!
Bullboard Posts